Janssen, Legend Biotech Strike Collaboration and License Agreement to Develop Investigational CAR-T Anti-Cancer … – Drug Discovery & Development
Drug Discovery & Development |
Janssen, Legend Biotech Strike Collaboration and License Agreement to Develop Investigational CAR–T Anti-Cancer …
Drug Discovery & Development Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson, announced that it has entered into a worldwide collaboration and license agreement with Legend Biotech USA Inc. and Legend Biotech Ireland Limited (“Legend”), subsidiaries of … Janssen buys into Legend's CART therapy Chinese biotech firm Genscript's shares jump by a third on US$350m Johnson & Johnson unit tie-up |
